Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$516,436,996
+$36,237,999 QoQ
Shares Held
2,052,285
-7.0% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#79
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $3,276,463,441 across 12 Drug Manufacturers - General names. ABBV ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
682,818 | $818,992,461 | |
| 2 | JNJ |
Johnson & Johnson
|
2,447,058 | $621,479,319 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,309,756 | $553,803,646 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,052,285 | $516,436,996 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,222,190 | $185,662,586 | |
| 6 | AMGN |
Amgen Inc
|
489,514 | $177,262,808 | |
| 7 | PFE |
Pfizer Inc
|
6,163,309 | $148,412,479 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,003,515 | $126,784,084 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $516,436,996 | 2,052,285 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $480,198,997 | 2,207,913 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $516,305,371 | 2,259,641 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $522,219,018 | 2,255,416 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $431,146,441 | 2,322,737 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $471,581,539 | 2,250,771 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $313,077,368 | 1,761,831 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $392,326,405 | 1,986,664 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $351,594,387 | 2,049,874 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $410,579,594 | 2,254,693 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $352,371,095 | 2,273,802 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $215,185,251 | 1,443,615 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $213,021,330 | 1,581,098 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $436,016,555 | 2,735,876 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $458,516,980 | 2,837,182 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $384,846,501 | 2,867,495 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $463,749,332 | 3,027,875 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $585,119,831 | 3,609,400 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $657,343,573 | 4,854,827 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $504,544,339 | 4,677,337 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $530,775,672 | 4,712,142 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $494,335,755 | 4,567,878 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $462,009,902 | 4,311,805 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $361,410,001 | 4,126,156 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $421,237,949 | 4,290,466 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $299,662,276 | 3,933,092 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||